x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) with Preserved Ejection Fraction
Study Number
F16094
Summary
The purpose of this study is to evaluate the effect of LCZ696 compared to valsartan in the reduction of cardiovascular death and heart failure(HF) hospitalizations in patients with HF with preserved ejection fraction. 
Phase (?)
Phase III
Sponsor (?)
Contact

Gaylin Petty

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0